United States · FDA National Drug Code directory

Buspirone Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-8086_c98271e1-13bb-44a2-bdb1-22e6d682450c
Product NDC
68788-8086
Form
TABLET
Composition / generic term
Buspirone Hydrochloride
Labeler
Preferred Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20211005
Source listing expiry
20271231

Source-listed ingredients

  • BUSPIRONE HYDROCHLORIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE, PLASTIC (68788-8086-1) · 68788-8086-1
  • 30 TABLET in 1 BOTTLE, PLASTIC (68788-8086-3) · 68788-8086-3
  • 60 TABLET in 1 BOTTLE, PLASTIC (68788-8086-6) · 68788-8086-6
  • 90 TABLET in 1 BOTTLE, PLASTIC (68788-8086-9) · 68788-8086-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Buspirone Hydrochloride — United States | Molindra Medicines